Trial · NCT02548351
Adverse events1,854
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,854
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Pruritus | Skin and subcutaneous tissue disorders | OCA 10 Milligrams (mg) | 294 | 825 | |
| other | Pruritus | Skin and subcutaneous tissue disorders | OCA 25 mg | 470 | 827 | |
| other | Pruritus | Skin and subcutaneous tissue disorders | Placebo | 210 | 825 | |
| other | Rash | Skin and subcutaneous tissue disorders | OCA 10 Milligrams (mg) | 46 | 825 | |
| other | Rash | Skin and subcutaneous tissue disorders | OCA 25 mg | 61 | 827 | |
| other | Rash | Skin and subcutaneous tissue disorders | Placebo | 48 | 825 | |
| other | Pruritus generalised | Skin and subcutaneous tissue disorders | OCA 10 Milligrams (mg) | 15 | 825 | |
| other | Pruritus generalised | Skin and subcutaneous tissue disorders | OCA 25 mg | 55 | 827 | |
| other | Pruritus generalised | Skin and subcutaneous tissue disorders | Placebo | 13 | 825 | |
| other | Urinary tract infection | Infections and infestations | OCA 10 Milligrams (mg) | 147 | 825 | |
| other | Urinary tract infection | Infections and infestations | OCA 25 mg | 151 | 827 | |
| other | Urinary tract infection | Infections and infestations | Placebo | 133 | 825 | |
| other | Upper respiratory tract infection | Infections and infestations | OCA 10 Milligrams (mg) | 88 | 825 | |
| other | Upper respiratory tract infection | Infections and infestations | OCA 25 mg | 103 | 827 | |
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 84 | 825 | |
| other | Nasopharyngitis | Infections and infestations | OCA 10 Milligrams (mg) | 82 | 825 | |
| other | Nasopharyngitis | Infections and infestations | OCA 25 mg | 80 | 827 | |
| other | Nasopharyngitis | Infections and infestations | Placebo | 70 | 825 | |
| other | Sinusitis | Infections and infestations | OCA 10 Milligrams (mg) | 74 | 825 | |
| other | Sinusitis | Infections and infestations | OCA 25 mg | 73 | 827 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02548351/events